טוען...
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin.
Eleven patients with chronic inflammatory arthritides and haemoglobin concentrations less than 105 g/l with symptoms from their anaemia were treated with a dose of 250 IU/kg/week of recombinant human erythropoietin for six weeks. The treatment was given as subcutaneous injections five days a week. A...
שמור ב:
| הוצא לאור ב: | Ann Rheum Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
1992
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1616357/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.51.6.747 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|